Tat-regulated expression of RNA interference: Triggers for the treatment of HIV infection

Hoshang Unwalla, John J. Rossi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

HIV infection is a lifelong problem requiring continual medication for suppressing viral replication. Current strategies of antiretroviral drug combinations have proven effective in prolonging the time from infection to the symptoms of AIDS. Nevertheless, chemotherapy is not without its problems, which include toxicities and eventual emergence of virus mutants that are resistant to current antiretrovirals. Gene therapy refers to the introduction of effector oligonucleotides to transiently or stably alter gene expression or the delivery and expression of an exogenous gene within a specific target cell. A number of studies have demonstrated effective silencing/inhibition of HIV-1 replication by using RNA-based effector oligonucleotides for RNA interference. In this study, we have taken advantage of lentiviral vector-mediated delivery of anti-HIV short hairpin RNA for the treatment of HIV infection in hematopoietic cells.

Original languageEnglish
Pages (from-to)40-43
Number of pages4
JournalCurrent HIV/AIDS Reports
Volume5
Issue number1
DOIs
StatePublished - Feb 1 2008

Fingerprint

RNA Interference
Oligonucleotides
HIV Infections
Gene Expression
Drug Combinations
Genetic Therapy
Small Interfering RNA
HIV-1
Acquired Immunodeficiency Syndrome
HIV
RNA
Viruses
Drug Therapy
Therapeutics
Infection

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Tat-regulated expression of RNA interference : Triggers for the treatment of HIV infection. / Unwalla, Hoshang; Rossi, John J.

In: Current HIV/AIDS Reports, Vol. 5, No. 1, 01.02.2008, p. 40-43.

Research output: Contribution to journalArticle

Unwalla, Hoshang ; Rossi, John J. / Tat-regulated expression of RNA interference : Triggers for the treatment of HIV infection. In: Current HIV/AIDS Reports. 2008 ; Vol. 5, No. 1. pp. 40-43.
@article{d8c0ac1b2fa44ff6ac440f7d439d4a20,
title = "Tat-regulated expression of RNA interference: Triggers for the treatment of HIV infection",
abstract = "HIV infection is a lifelong problem requiring continual medication for suppressing viral replication. Current strategies of antiretroviral drug combinations have proven effective in prolonging the time from infection to the symptoms of AIDS. Nevertheless, chemotherapy is not without its problems, which include toxicities and eventual emergence of virus mutants that are resistant to current antiretrovirals. Gene therapy refers to the introduction of effector oligonucleotides to transiently or stably alter gene expression or the delivery and expression of an exogenous gene within a specific target cell. A number of studies have demonstrated effective silencing/inhibition of HIV-1 replication by using RNA-based effector oligonucleotides for RNA interference. In this study, we have taken advantage of lentiviral vector-mediated delivery of anti-HIV short hairpin RNA for the treatment of HIV infection in hematopoietic cells.",
author = "Hoshang Unwalla and Rossi, {John J.}",
year = "2008",
month = "2",
day = "1",
doi = "10.1007/s11904-008-0007-3",
language = "English",
volume = "5",
pages = "40--43",
journal = "Current HIV/AIDS Reports",
issn = "1548-3568",
publisher = "Current Science, Inc.",
number = "1",

}

TY - JOUR

T1 - Tat-regulated expression of RNA interference

T2 - Triggers for the treatment of HIV infection

AU - Unwalla, Hoshang

AU - Rossi, John J.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - HIV infection is a lifelong problem requiring continual medication for suppressing viral replication. Current strategies of antiretroviral drug combinations have proven effective in prolonging the time from infection to the symptoms of AIDS. Nevertheless, chemotherapy is not without its problems, which include toxicities and eventual emergence of virus mutants that are resistant to current antiretrovirals. Gene therapy refers to the introduction of effector oligonucleotides to transiently or stably alter gene expression or the delivery and expression of an exogenous gene within a specific target cell. A number of studies have demonstrated effective silencing/inhibition of HIV-1 replication by using RNA-based effector oligonucleotides for RNA interference. In this study, we have taken advantage of lentiviral vector-mediated delivery of anti-HIV short hairpin RNA for the treatment of HIV infection in hematopoietic cells.

AB - HIV infection is a lifelong problem requiring continual medication for suppressing viral replication. Current strategies of antiretroviral drug combinations have proven effective in prolonging the time from infection to the symptoms of AIDS. Nevertheless, chemotherapy is not without its problems, which include toxicities and eventual emergence of virus mutants that are resistant to current antiretrovirals. Gene therapy refers to the introduction of effector oligonucleotides to transiently or stably alter gene expression or the delivery and expression of an exogenous gene within a specific target cell. A number of studies have demonstrated effective silencing/inhibition of HIV-1 replication by using RNA-based effector oligonucleotides for RNA interference. In this study, we have taken advantage of lentiviral vector-mediated delivery of anti-HIV short hairpin RNA for the treatment of HIV infection in hematopoietic cells.

UR - http://www.scopus.com/inward/record.url?scp=41649098052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41649098052&partnerID=8YFLogxK

U2 - 10.1007/s11904-008-0007-3

DO - 10.1007/s11904-008-0007-3

M3 - Article

C2 - 18417034

AN - SCOPUS:41649098052

VL - 5

SP - 40

EP - 43

JO - Current HIV/AIDS Reports

JF - Current HIV/AIDS Reports

SN - 1548-3568

IS - 1

ER -